Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Immutep
Sponsor

Immutep

France Batiment 7 Le Pythagore Route De L Orme Route Departementale, 128 Parc Des Algorithmes, 91190, France

About the sponsor

Immutep supports clinical research in advanced and metastatic non-small cell lung cancer, with interest in immunotherapy combinations built around pembrolizumab and chemotherapy for PD-L1-unselected disease.

  • Immune checkpoint therapy
  • Combination immuno-oncology
  • Late-stage lung cancer

The sponsor’s oncology portfolio includes treatment strategies aimed at improving outcomes in metastatic lung cancer through immune-based regimens.

About Specializations

Immutep runs clinical trials in conditions such as Non-small cell lung cancer metastatic, Head and neck cancer metastatic, Breast cancer stage IV, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Non-small cell lung cancer metastatic

Not recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Immutep

Head and neck cancer metastatic

Not recruiting
Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Eftilagimod Alfa
  • Sponsor:Immutep

Breast cancer stage IV

Not recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Eftilagimod Alfa
  • Sponsor:Immutep

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.